drugset / Trial / NCT00880672
Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate
Phase 4
Completed
40 enrolled
Seoul National University Hospital
GlaxoSmithKline · collabThe Korean Urological Association · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether dutasteride may influence the expression of angiogenesis factors such as hypoxia inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF) in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH).
Timeline
- Start
- 2008-01
- Primary completion
- 2008-12
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dutasteride | Small molecule | 5 mg | Oral |